openPR Logo
Press release

Driving Male Hypogonadism Market Growth in 2025: The Role of Rising Infertility Rates Fueled Male Hypogonadism Market Growth

09-12-2025 07:58 AM CET | Health & Medicine

Press release from: The Business Research Company

Male Hypogonadism

Male Hypogonadism

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Male Hypogonadism Market Size Growth Forecast: What to Expect by 2025?
In recent times, the market size for male hypogonadism has seen considerable growth. From a market worth of $3.75 billion in 2024, it is projected to climb to $3.95 billion in 2025, experiencing a 5.3% compound annual growth rate (CAGR). The surge in growth during the previous years is as a result of factors such as an aging population, increased awareness, diagnostic measures, lifestyle influences, chronic diseases, and trends in seeking treatment.

How Will the Male Hypogonadism Market Size Evolve and Grow by 2029?
The market size of male hypogonadism is predicted to experience substantial growth in the upcoming years. It is estimated to reach "$4.99 billion by 2029 with a compound annual growth rate (CAGR) of 6.0%. This anticipated growth within the forecast period can be associated with increasing awareness, the prevalence of lifestyle-related disorders, advancements in treatment strategies, an increased focus on male health, telemedicine, and healthcare accessibility. Key trends within this forecast period involve a focus on mental and sexual health, investigation into nutraceuticals and lifestyle modifications, market growth in developing economies, partnerships in research, and an emphasis on long-term safety and tracking.

View the full report here:
https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report

What Drivers Are Propelling the Growth of Male Hypogonadism Market Forward?
The escalating infertility rates are anticipated to fuel the expansion of the male hypogonadism market. Infertility denotes a condition impacting the male or female reproductive tract identified by the incapability to conceive following a year or more of regular, unprotected sexual engagement. Male hypogonadism, a potential root cause of male infertility that could result in reduced sperm production, is predicted to spur the male hypogonadism market's growth due to rising male infertility occurrences. For example, data from the Office for National Statistics, a UK governmental department, revealed that the total fertility rate (TFR) rose to 1.49 children per woman in 2022, an increase from 1.55 in 2021. Consequently, the growing infertility rate is stimulating the expansion of the male hypogonadism market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9969&type=smp

What Long-Term Trends Will Define the Future of the Male Hypogonadism Market?
The emergence of product innovations is a significant trend observed in the male hypogonadism market. Businesses operating in this sector are creating innovative products to maintain their market share. In June 2022, Halozyme, a biotechnology firm based in the United States, introduced Tlando, an oral therapy for testosterone replacement in the treatment of male hypogonadism. Tlando, a prescription medication containing testosterone, is the first FDA-approved oral testosterone treatment. It is prescribed to adult male patients suffering from specific medical conditions that result in low or absent testosterone levels.

What Are the Key Segments in the Male Hypogonadism Market?
The male hypogonadism market covered in this report is segmented -

1) By Type: Klinefelters Syndrome, Kallmann Syndrome, Pituitary Disorders, Other Types
2) By Drug Delivery: Topical Gels, Injectables, Transdermal Patches, Other Drug Deliveries
3) By Therapy: Testosterone Therapy, Gonadotropin-Releasing Hormone Therapy

Subsegments:
1) By Klinefelter's Syndrome: 47,XXY Syndrome, Other Variants
2) By Kallmann Syndrome: Isolated Kallmann Syndrome, Syndromic Kallmann Syndrome
3) By Pituitary Disorders: Hypopituitarism, Pituitary Tumors, Other Pituitary Disorders
4) By Other Types: Androgen Insensitivity Syndrome, Testicular Dysgenesis Syndrome, Genetic Mutations And Disorders

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9969&type=smp

Who Are the Key Players Shaping the Male Hypogonadism Market's Competitive Landscape?
Major companies operating in the male hypogonadism market include Pfizer Inc., Bayer AG, Eli Lilly and Company Ltd., Endo International plc., Merck & Co. Inc., Ferring Pharmaceuticals, Finox Biotech AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Perrigo Company plc, IBSA Institut Biochimique SA, Sun Pharmaceutical Industries Limited, Glenmark Pharmaceuticals Limited, Antares Pharma Inc., Zydus Cadila LLC, Besins Healthcare Ltd., Clarus Therapeutics Holdings Inc., Foresee Pharmaceuticals Co. Ltd., Lipocine Inc., Myovant Sciences Ltd., Sandoz International GmbH, Shionogi & Co. Ltd., TherapeuticsMD Inc., Viking Therapeutics Inc.

What Geographic Markets Are Powering Growth in the Male Hypogonadism Market?
North America was the largest region in the male hypogonadism market in 2024. Asia-Pacific is expected to be the fastest-growing region in the male hypogonadism market report during the forecast period. The regions covered in the male hypogonadism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9969

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Driving Male Hypogonadism Market Growth in 2025: The Role of Rising Infertility Rates Fueled Male Hypogonadism Market Growth here

News-ID: 4180210 • Views:

More Releases from The Business Research Company

Elevating Demand For Digestive Health Supplements Driven By The Surge In Digestive Disease Prevalence: A Key Catalyst Accelerating Digestive Health Supplements Market Growth in 2025
Elevating Demand For Digestive Health Supplements Driven By The Surge In Digesti …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Digestive Health Supplements Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market for digestive health supplements has demonstrated substantial growth in the past few years. It is projected to increase from $17.2 billion in 2024 to $18.86 billion in 2025, with a compound annual
Antivenom Market Trends That Will Shape the Next Decade: Insights from Advancements in Antivenom Development
Antivenom Market Trends That Will Shape the Next Decade: Insights from Advanceme …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Antivenom Market Size By 2025? The size of the antivenom market has witnessed robust growth in the past few years. The market's value, which stood at $1.92 billion in 2024, is projected to increase to $2.04 billion in 2025, signaling a compound annual growth rate
Key Trends Influencing the Growth of the Alzheimer's Drugs Market in 2025: Kisunla Receives Food and Drug Administration (FDA) Approval As First Amyloid Plaque-Targeting Therapy For Early Alzheimer's
Key Trends Influencing the Growth of the Alzheimer's Drugs Market in 2025: Kisun …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Alzheimer's Drugs Market Through 2025? The market size of Alzheimer's drugs has notably expanded over the past few years. The forecast suggests an increase from $9.33 billion in 2024 to $10.09 billion in 2025, with a compound annual growth rate (CAGR) of
Future of the Contraceptives Market: Trends, Innovations, and Key Forecasts Through 2034
Future of the Contraceptives Market: Trends, Innovations, and Key Forecasts Thro …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Contraceptives Market Size Growth Forecast: What to Expect by 2025? The market size for contraceptives has seen robust growth in the past few years. This market is projected to expand from $27.92 billion in 2024 to $29.74 billion in 2025, with a compound annual growth rate (CAGR) of 6.5%.

All 5 Releases


More Releases for Male

Global Male Hypogonadism Market 2023: North America to Remain Largest Market for …
Male hypogonadism refers to a medical condition in which the male body is unable to produce adequate levels of testosterone, the hormone responsible for the development and maintenance of male sexual characteristics. This condition can have a significant impact on a man's physical and emotional health, including reduced muscle mass, decreased bone density, and decreased The male hypogonadism market encompasses the pharmaceuticals and therapies used to treat this condition. The
Global Male Hypogonadism Market 2023: North America to Remain Largest Market for …
The Male Hypogonadism Market is an emerging segment in the medical industry. This condition affects millions of men around the world and can have serious implications for their physical and mental health. Treatment options are available to help manage symptoms, but often come with associated side effects. The Male Hypogonadism Market is expected to experience significant growth over the coming years as more therapies become available. Pharmaceutical companies are investing
Global Male Hypogonadism Market 2023: North America to Remain Largest Market for …
The male hypogonadism market is a segment of the larger pharmaceutical industry that is focused on developing treatments for male hypogonadism, a condition in which the testes do not produce enough testosterone. In 2022, the male hypogonadism market is expected to continue to grow, driven by the increasing prevalence of the condition and the development of new treatments. The market is expected to be worth billions of dollars in 2022, with strong
Global Male Hypogonadism Market 2023: North America to Remain Largest Market for …
Male hypogonadism is a condition in which the body does not produce enough testosterone, the primary male sex hormone. This can lead to a variety of symptoms, including decreased, erectile dysfunction, fatigue, and muscle weakness. Male hypogonadism is typically treated with testosterone replacement therapy (TRT), which can be administered in several forms, such as gels, injections, and pellets. Request For Free Sample Report of "Male Hypogonadism Market"@ https://www.persistencemarketresearch.com/samples/22303 The global male hypogonadism
Male Origin Male Enhancement - Restore Testosterone, Best Reviews, Male Enhancem …
Male Origin Male Enhancement You need to go to your most unmistakable potential in the room, paying little mind to your age. Taking everything into account, you're a man. You ought to be OK at sex. Luckily, Male Origin Male Enhancement Male Enhancement can help with settling any sexual dysfunctions that are holding you down. For example, if you fight with unwinding when you undeniably shouldn't be limp, this can
Libopro Male Enhance Review-Does Libopro Male Enhance Work-Complete Info
LiboPro Male Enhancement to an external site. Herbal is a herbal nutritional supplement that contains a effective mixture of the strongest natural ingredients that help you could Max out your performance. This supplement makes use of a natural composition as a way to assure you the safest results without Side Effects. This is the best quality manner right now to increase your sexual potential and revel in existence the way